This Week: 'Home Run' in Prostate Ca, Cannabis Risks

(MedPage Today) -- Early docetaxel and anti-androgen therapy extended survival dramatically in metastatic prostate cancer, and NIDA officials published a review of marijuana's health risks that may have overstated the case.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news